AAAAAA
Results:
1-7
|
Results: 7
Authors:
Campomenosi, P
Monti, P
Aprile, A
Abbondandolo, A
Frebourg, T
Gold, B
Crook, T
Inga, A
Resnick, MA
Iggo, R
Fronza, G
Citation: P. Campomenosi et al., p53 mutants can often transactivate promoters containing a p21 but not Baxor PIG3 responsive elements, ONCOGENE, 20(27), 2001, pp. 3573-3579
Authors:
Meinhold-Heerlein, I
Ninci, E
Ikenberg, H
Brandstetter, T
Ihling, C
Schwenk, I
Straub, A
Schmitt, B
Bettendorf, H
Iggo, R
Bauknecht, T
Citation: I. Meinhold-heerlein et al., Evaluation of methods to detect p53 mutations in ovarian cancer, ONCOL-BASEL, 60(2), 2001, pp. 176-188
Authors:
Brunori, M
Malerba, M
Kashiwazaki, H
Iggo, R
Citation: M. Brunori et al., Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway, J VIROLOGY, 75(6), 2001, pp. 2857-2865
Authors:
Gagnebin, J
Brunori, M
Otter, M
Juillerat-Jeanneret, L
Monnier, P
Iggo, R
Citation: J. Gagnebin et al., A photosensitising adenovirus for photodynamic therapy, GENE THER, 6(10), 1999, pp. 1742-1750
Authors:
Saller, E
Tom, E
Brunori, M
Otter, M
Estreicher, A
Mack, DH
Iggo, R
Citation: E. Saller et al., Increased apoptosis induction by 121F mutant p53, EMBO J, 18(16), 1999, pp. 4424-4437
Authors:
Yuan, ZQ
Wong, N
Foulkes, WD
Alpert, L
Manganaro, F
Andreutti-Zaugg, C
Iggo, R
Anthony, K
Hsieh, E
Redston, M
Pinsky, L
Trifiro, M
Gordon, PH
Lasko, D
Citation: Zq. Yuan et al., A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening, J MED GENET, 36(10), 1999, pp. 790-793
Authors:
Chappuis, PO
Estreicher, A
Dieterich, B
Bonnefoi, H
Otter, M
Sappino, AP
Iggo, R
Citation: Po. Chappuis et al., Prognostic significance of p53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay, INT J CANC, 84(6), 1999, pp. 587-593
Risultati:
1-7
|